David C Dale1, Emily Dick2, Merideth Kelley1, Vahagn Makaryan1, Jim Connelly3, Audrey Anna Bolyard2. 1. Department of Medicine, University of Washington. 2. University of Washington, Severe Chronic Neutropenia International Registry, Seattle, Washington. 3. Department of Pediatrics, Vanderbilt University, Nashville, Tennessee, USA.
Abstract
PURPOSE OF REVIEW: WHIM syndrome (warts, hypogammaglobulinemia, immunodeficiency, myelokathexis, or WHIMs) is a very rare autosomal dominant immunodeficiency disorder attributable to mutations in CXCR4. We reviewed clinical manifestations in 24 patients in 9 families to expand understanding of this syndrome. RECENT FINDINGS: Warts, cellulitis and respiratory infections are common in patients with WHIMs. Less commonly these patients have congenital heart disease, human papilloma virus-associated malignancies (cervical and vulvular) and lymphomas. Hearing loss because of recurrent otitis media is another important complication. Treatment with granulocyte colony-stimulating factor is controversial; this review indicates that it is effective to prevent and treat infections based upon long-term observations of patients enrolled in the Severe Chronic Neutropenia International Registry. Understanding the natural history and diversity of this syndrome are important for ongoing clinical trials of novel agents to treat WHIMs. SUMMARY: WHIM syndrome has diverse manifestations; some features occur consistently in almost all patients, for example, neutropenia, lymphocytopenia and mild hypogammaglobulinemia. However, the clinical consequences are quite variable across patient cohorts and within families. Each complication is important as a cause for morbidity and a source for patient and family concerns.
PURPOSE OF REVIEW: WHIM syndrome (warts, hypogammaglobulinemia, immunodeficiency, myelokathexis, or WHIMs) is a very rare autosomal dominant immunodeficiency disorder attributable to mutations in CXCR4. We reviewed clinical manifestations in 24 patients in 9 families to expand understanding of this syndrome. RECENT FINDINGS: Warts, cellulitis and respiratory infections are common in patients with WHIMs. Less commonly these patients have congenital heart disease, human papilloma virus-associated malignancies (cervical and vulvular) and lymphomas. Hearing loss because of recurrent otitis media is another important complication. Treatment with granulocyte colony-stimulating factor is controversial; this review indicates that it is effective to prevent and treat infections based upon long-term observations of patients enrolled in the Severe Chronic Neutropenia International Registry. Understanding the natural history and diversity of this syndrome are important for ongoing clinical trials of novel agents to treat WHIMs. SUMMARY: WHIM syndrome has diverse manifestations; some features occur consistently in almost all patients, for example, neutropenia, lymphocytopenia and mild hypogammaglobulinemia. However, the clinical consequences are quite variable across patient cohorts and within families. Each complication is important as a cause for morbidity and a source for patient and family concerns.
Authors: David C Dale; Audrey Anna Bolyard; Merideth L Kelley; Ernest C Westrup; Vahagn Makaryan; Andrew Aprikyan; Brent Wood; Frank J Hsu Journal: Blood Date: 2011-08-11 Impact factor: 22.113
Authors: David H McDermott; Diana V Pastrana; Katherine R Calvo; Stefania Pittaluga; Daniel Velez; Elena Cho; Qian Liu; Hugh H Trout; João F Neves; Pamela J Gardner; David A Bianchi; Elizabeth A Blair; Emily M Landon; Susana L Silva; Christopher B Buck; Philip M Murphy Journal: N Engl J Med Date: 2019-01-10 Impact factor: 91.245
Authors: David H McDermott; Qian Liu; Jean Ulrick; Nana Kwatemaa; Sandra Anaya-O'Brien; Scott R Penzak; Joao Oliveira Filho; Debra A Long Priel; Corin Kelly; Mary Garofalo; Patricia Littel; Martha M Marquesen; Diane Hilligoss; Rosamma Decastro; Thomas A Fleisher; Douglas B Kuhns; Harry L Malech; Philip M Murphy Journal: Blood Date: 2011-09-02 Impact factor: 22.113
Authors: Paolo A Hernandez; Robert J Gorlin; John N Lukens; Shoichiro Taniuchi; Joze Bohinjec; Fleur Francois; Mary E Klotman; George A Diaz Journal: Nat Genet Date: 2003-05 Impact factor: 38.330
Authors: Lauren E Heusinkveld; Erin Yim; Alexander Yang; Ari B Azani; Qian Liu; Ji-Liang Gao; David H McDermott; Philip M Murphy Journal: Expert Opin Orphan Drugs Date: 2017-09-25 Impact factor: 0.694